Connection

JEFFREY J MOLLDREM to Epitopes, T-Lymphocyte

This is a "connection" page, showing publications JEFFREY J MOLLDREM has written about Epitopes, T-Lymphocyte.
Connection Strength

1.004
  1. What T cells see in WT-1. Blood. 2012 Aug 23; 120(8):1540-1.
    View in: PubMed
    Score: 0.377
  2. Two unique HLA-A*0201 restricted peptides derived from cyclin E as immunotherapeutic targets in leukemia. Leukemia. 2020 06; 34(6):1626-1636.
    View in: PubMed
    Score: 0.157
  3. Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes. Clin Cancer Res. 2019 04 15; 25(8):2610-2620.
    View in: PubMed
    Score: 0.147
  4. PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies. Leukemia. 2017 03; 31(3):697-704.
    View in: PubMed
    Score: 0.125
  5. Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data. PLoS One. 2011; 6(8):e23217.
    View in: PubMed
    Score: 0.088
  6. Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice. Blood. 2011 Aug 25; 118(8):2159-69.
    View in: PubMed
    Score: 0.087
  7. Targeting human B-cell malignancies through Ig light chain-specific cytotoxic T lymphocytes. Clin Cancer Res. 2011 Sep 15; 17(18):5945-52.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.